References
1. Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145:1082-123.
2. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr., Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report–Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391-7.
3. El Turki A, Smith H, Llewellyn C, Jones CJ. A systematic review of patients’, parents’ and healthcare professionals’ adrenaline auto-injector administration techniques. EMJ. 2017;34:403-16.
4. Saleh-Langenberg J, de Vries S, Bak E, Kollen BJ, Flokstra-de Blok BMJ, Dubois AEJ. Incomplete and incorrect epinephrine auto-injector training to food-allergic patients by pharmacists in the Netherlands. Pediatr Allergy Immunol. 2017;28:238-44.
5. Dumeier HK, Richter LA, Neininger MP, Prenzel F, Kiess W, Bertsche A, et al. Knowledge of allergies and performance in epinephrine auto-injector use: a controlled intervention in preschool teachers. Eur J Pediatr . 2018;177:575-81.
6. Robinson MN, Dharmage SC, Tang ML. Comparison of adrenaline auto-injector devices: ease of use and ability to recall use. Pediatr Allergy Immunol. 2014;25:462-7.
7. Portnoy J, Wade RL, Kessler C. Patient carrying time, confidence, and training with epinephrine autoinjectors: The RACE Survey. J Allergy Clin Immunol Pract. 2019;7:2252-61.